36284-77-2

Basic information

• Product Name: Hederasaponin B
• Synonyms: Hederacolchiside C;Hederacoside B;Hederagenin B;Saponin Pl3;Tauroside G2;Tauroside St-G2;Akebasaponin PJ3;Hederasaponin B
• CAS NO: 36284-77-2
• Molecular Formula: C59H96O25
• Molecular Weight: 1205.379
• Product Categories: chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract
• Mol File: 36284-77-2.mol
• Article Data: 2

Chemical Properties

• Melting Point: 223-226℃
• Appearance: /
• Density: 1.46
• CAS DataBase Reference: Hederasaponin B(CAS DataBase Reference)
• NIST Chemistry Reference: Hederasaponin B(36284-77-2)
• EPA Substance Registry System: Hederasaponin B(36284-77-2)

Safety Data

• Hazardous Substances Data: 36284-77-2(Hazardous Substances Data)

Usage

Description

Hederasaponin B is a steroidal saponin derived from Hedera helix, commonly known as the English ivy. It exhibits antiviral properties and has potential antitumor activity, making it a compound of interest for various pharmaceutical applications.

Uses

Used in Antiviral Applications:
Hederasaponin B is used as an antiviral agent for the treatment of hand, foot, and mouth disease (HFMD). Its antiviral properties help in managing the symptoms and progression of the disease.
Used in Antitumor Applications:
Hederasaponin B is used as a potential antitumor agent due to its steroidal saponin nature. It may be employed in the development of pharmaceuticals targeting cancer cells, contributing to the fight against various types of cancer.
Used in Pharmaceutical Industry:
Hederasaponin B is used as a key compound in the pharmaceutical industry for its antiviral and potential antitumor properties. Its development and application in drug formulations aim to provide effective treatments for specific diseases and conditions.

Upstream product

• 114906-75-1 ciwujianoside C₄ 

Downstream Products

• 75026-25-4 β-hederin 
• 109606-00-0 methyl α-L-rhamnosyl-(1->4)-O-β-D-glucopyranosyl-(1->6)-(α and β)-D-glucopyranoside 

Relevant articles and documents

Synthesis, biological evaluation and structure-activity relationship studies of hederacolchiside E and its derivatives as potential anti-Alzheimer agents

Inspired by the previously reported neuroprotective activity of hederacolchiside E (1), we synthesized hederacolchiside E for the first time along with eleven of its derivatives. The neuroprotective effects of these compounds were further evaluated agains